UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000020041
Receipt number R000023124
Scientific Title Alleviating drymouth by mask-wearing for head and neck cancer patients on chemoradiotherapy
Date of disclosure of the study information 2015/12/11
Last modified on 2015/12/25 18:39:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Alleviating drymouth by mask-wearing
for head and neck cancer patients
on chemoradiotherapy

Acronym

Alleviating drymouth by mask-wearing
for head and neck cancer patients
on chemoradiotherapy

Scientific Title

Alleviating drymouth by mask-wearing
for head and neck cancer patients
on chemoradiotherapy

Scientific Title:Acronym

Alleviating drymouth by mask-wearing
for head and neck cancer patients
on chemoradiotherapy

Region

Japan


Condition

Condition

Head and neck cancer

Classification by specialty

Oto-rhino-laryngology Nursing

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The efficacy of mask-wearing is to be studied for drymouth patients with head and neck cancer on chemoradiotherapy.The patients will wear masks from one day before chemoradiotherapy starts through two weeks after the completion of the radiotherapy.Two kinds of masks, wet and paper masks are to be compared.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Evaluation by measured moisture/ oral mucosa
from one day before chemoradiotherapy starts
through two weeks after the completion of the radiotherapy.

Key secondary outcomes

subjective dryness/ oral cavity
quality/ saliva
severity/ inflamation in oral cavity
pain/ oral cavity
food intake
aspiration pneumonia


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Group A:wet mask wearing for 9weeks

Interventions/Control_2

Group B:paper mask wearing for 9weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

81 years-old >

Gender

Male and Female

Key inclusion criteria

1.The patints on chemotherapy,Cisplatin 20mg/m and Docetaxel10mg/m2,once a week, 6 cycles with the radiotherapy 66Gy or 70Gy
2.PS 0~1
3.able to communication
4.able to wear mask

Key exclusion criteria

1.Patints of the dry mouth or Sjogren's syndrome
2.Patints of respiratory disturbance
3.Patints allergic to mask

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Satomi Miki

Organization

Osaka University Hospital

Division name

East 13th Floor

Zip code


Address

2-15 Yamadaoka,Suita,Osaka,Japan

TEL

06-6879-6500

Email

mikistm@hosp.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Satomi Miki

Organization

Osaka University Hospital

Division name

East 13th Floor

Zip code


Address

2-15 Yamadaoka,Suita,Osaka,Japan

TEL

06-6879-6500

Homepage URL


Email

mikistm@hosp.med.osaka-u.ac.jp


Sponsor or person

Institute

East 13th Floor,Osaka University Hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪大学医学部附属病院(大阪府)


Other administrative information

Date of disclosure of the study information

2015 Year 12 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2015 Year 12 Month 11 Day

Date of IRB


Anticipated trial start date

2015 Year 12 Month 11 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 12 Month 02 Day

Last modified on

2015 Year 12 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023124


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name